تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies AstraZeneca/ IQVIA Ongoing Eculizumab 3 ALXN-MG-50 Aseer Hospital (Abha)
A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG Argenx BV / Balsam Ongoing Efgartigimod 3 ARGX-113-2315 King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial with Open Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Patients with Primary Sjögren’s Disease Argenx BV / IQVIA Ongoing Efgartigimod 3 ARGX-113-2306 King Faisal Specialist Hospital and Research Center (Riyadh) , King Khalid University Hospital (Riyadh)
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) Novartis Ongoing Rapcabtagene Autoleucel (YTB323) 2 CYTB323I12201 King Faisal Specialist Hospital and Research Center (Riyadh)
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH) GB002, Inc / Balsam Ongoing Seralutinib 3 GB002-3102 King Faisal Specialist Hospital and Research Center (Riyadh) , King Fahad Medical City (Riyadh)
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant Vertex / CTI Ongoing VX880 3 VX23-880-102 King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh)
The prolonged effect of spinal dexmedetomidine versus Intravenous dexmedetomidine on spinal anesthesia using isobaric Bupivacaine in Orthopedic Surgeries, Randomized clinical trial King Abdullah International Medical Research Center (Riyadh) Ongoing Dexmedetomidine 3 ICTR24/001/11 King Abdulaziz Medical City NG (Riyadh)
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia Vertex / CTI Ongoing VX 880 3 VX20-880-101 King Abdulaziz Hospital NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh)
Evaluation of safety and efficacy of non-anesthesia provider-administered different anesthetic regimens during colonoscopy: a single center, prospective double blind, randomized study PI initiated Ongoing Propofol 4 6074515 King Saud Hospital (Unaizah)
A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease Novo Nordisk Ongoing Etavopivat 3 NN7535-7807 King Abdulaziz Hospital NG (Al Ahsa), King Faisal Specialist Hospital and Research Center (Riyadh) ,Imam Abdulrahman Al Faisal Hospital NG (Dammam)
عرض 1 - 10 من 489